Cosmo Bio Co

Cosmo Bio Co Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Cosmo Bio Co (3386.T) as of Oct 27, 2026 is 56.84. In the previous year, Days Inventory Outstanding (DIO) was 57.95 — a change of -1.92% (lower).

Days Inventory Outstanding

56.84

YoY

-1.92%

Last updated:

Days Inventory Outstanding (DIO) of Cosmo Bio Co is 2025 56.84 . Days Inventory Outstanding (DIO) of Cosmo Bio Co was 2024 57.95 . It decreases by -1.92% lower compared to the previous year.

The Cosmo Bio Co Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2018
80.19 JPY
Jan 1, 2019
66.80 JPY
Jan 1, 2020
45.51 JPY
Jan 1, 2021
56.53 JPY
Jan 1, 2022
67.72 JPY
Jan 1, 2023
62.21 JPY
Jan 1, 2024
57.95 JPY
Jan 1, 2025
56.84 JPY
The Cosmo Bio Co Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
56.84-1.92%
57.95-6.85%
62.21-8.13%
67.72+19.79%
56.53+24.21%
45.51-31.87%
66.80-16.69%
80.19-22.10%
102.94+8.05%
95.27+13.63%
83.84-0.35%
84.14—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cosmo Bio Co Stock analysis

What does Cosmo Bio Co do? Cosmo Bio Co., Ltd. generates revenue through the export, import, and sale of bio-research reagents, instruments, and software, as well as clinical diagnostics. The company imports research reagents primarily from the United States and Europe, which are utilized in life science research. In the equipment segment, Cosmo Bio handles specialized life science research equipment sourced from domestic and overseas suppliers, targeting domestic market sales. The equipment includes ultrasonic cell disruption devices, bioimaging systems, and research consumables. Clinical test drugs are sold mainly to hospitals and testing centers. The company's research reagents business focuses on importing products from the United States and Europe, which are prioritized for life science research applications. Equipment sales target domestic customers seeking specialized life science research tools, including ultrasonic cell disruption equipment and bioimaging-related devices. Clinical diagnostics products are distributed to hospitals and testing centers for medical testing purposes. Cosmo Bio's revenue streams are divided into three main segments: bio-research reagents, life science equipment, and clinical diagnostics. The reagents segment relies on imports from the United States and Europe, while the equipment segment features products like ultrasonic cell disruption equipment and bioimaging systems. Clinical diagnostics products are sold to hospitals and testing centers as test drugs for medical use. Cosmo Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cosmo Bio Co stock

Days Inventory Outstanding (DIO) of Cosmo Bio Co is 56.84 in 2025.

Days Inventory Outstanding (DIO) of Cosmo Bio Co changed from 57.95 to 56.84, representing a -1.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Cosmo Bio Co since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Cosmo Bio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Cosmo Bio Co

All Key Metrics — Cosmo Bio Co